Hikma Specialty USA Inc.
5 drugs in NADAC|0 Generic,5 Brand
Hikma Specialty USA Inc. lists 5 NDCs in the CMS NADAC file (0 generic, 5 brand), at an average NADAC of $17.11 per unit, with a week-over-week move of +0.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
0G / 5B
Avg Price / Unit
$17.1067
$6.03 – $59.77
Avg 7d Change
+0.26%
Across 4 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Colchicine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Alkaloid therapeutic class
Review the broader class where Hikma Specialty USA Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Hikma Specialty USA Inc. make?
Hikma Specialty USA Inc. lists 5 NDCs in the CMS NADAC file — 0 generic and 5 brand products.
What is the average price of Hikma Specialty USA Inc. drugs?
The average NADAC across Hikma Specialty USA Inc.'s portfolio is $17.1067 per unit, ranging from $6.0293 to $59.7742.
What types of drugs does Hikma Specialty USA Inc. make?
Hikma Specialty USA Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are Alkaloid (3), Opioid Antagonist (1), Corticosteroid (1), Histamine-1 Receptor Antagonist (1), Histamine-1 Receptor Inhibitor (1).
Has Hikma Specialty USA Inc. had any drug recalls?
No FDA enforcement recalls are matched to Hikma Specialty USA Inc. in the openFDA feed.
How has Hikma Specialty USA Inc.'s pricing changed recently?
Over the past 7 days, 4 Hikma Specialty USA Inc. products rose and 0 fell, with a portfolio-wide average change of +0.3%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KLOXXADO 8 MG NASAL SPRAY Naloxone HCL | $59.7742 per EA | +0.05% |
RYALTRIS 665-25 MCG SPRAY olopatadine hydrochloride and mometasone furoate | $7.6715 per GM | — |
MITIGARE 0.6 MG CAPSULE Colchicine | $6.0293 per EA | +0.33% |
MITIGARE 0.6 MG CAPSULE Colchicine | $6.0293 per EA | +0.33% |
MITIGARE 0.6 MG CAPSULE Colchicine | $6.0293 per EA | +0.33% |